
    
      The enrolled patients will be grouped into active or latent tuberculosis according to the
      bacteriological evidence of TB. The TB-antigen responsive T cell markers will be examined.
      The performance of each T cell marker for the diagnosis of active TB will be systematically
      evaluated.
    
  